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Medical devices and supply companies are under enormous pressure to fulfill trade requirements dictated 
by current global markets, especially by the EU, although it is largely recognized that the innovative 
medical devices and procedures can considerably improve diagnostics and shorten therapeutic cycles. 
There are more than 8000 generic medical device groups where some devices contain drugs. The EU 
increases the demand for better regulatory frameworks to ensure that products entering the market are 
safe and efficient, even if they are essential for people's health and quality of life, and the industry that 
provides them plays a significant role in the economy. New treatment methods and innovative products are 
not  easy  to  position  in  the  EU  market,  and  for  this  reason,  one  of  the  major  issues  for  companies 
developing and producing medical devices is to be updated on the regulatory requirements and implement 
them. 
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Introduction 
Medical devices and supply companies are under enormous pressure to fulfill trade requirements 
dictated  by  current  global  markets.  Simultaneously,  the  medical  devices  become  even  more 
important  in  the  health  care  sector,  because  innovative  medical  devices  and  procedures  can 
considerably  improve  diagnostics  and  shorten  therapeutic  cycles.  Against  this  backdrop, 
international  standardization  of  products  and  prices,  entry  into  emerging  markets,  product 
bundling and integrated treatment solutions are gaining in importance. For the moment, there are 
more than 8000 generic medical device groups where some devices contain drugs. This is the 
main reason why the EU increases the demand for better regulatory frameworks to ensure that 
products entering the market are safe and efficient, even if they are essential for people's health 
and quality of life, and the industry that provides them plays a significant role in the economy. 
New treatment methods and innovative products are not easy to position in the EU market, and 
for this reason one of the major issues for companies developing and producing medical devices 
is to be updated on the regulatory requirements and implement them in the process. Besides, 
providers wishing to stand out from the competition need creative strategies, quality marketing, 
targeted branding and customized service. All of them have to develop and implement best-in-
class operating models that help them outperform the market. 486 
 
1. Defining the medical devices 
According to the European Union
317 definition, “Medical devices are […] articles which are 
intended to be used for a medical purpose. The medical purpose is assigned to a product by the 
manufacturer. The manufacturer determines through the label, the instruction for use and the 
promotional material related to a given device its specific medical purpose. As the directive aims 
essentially  at  the  protection  of  patients  and  users,  the  medical  purpose  relates  in  general  to 
finished products regardless of whether they are intended to be used alone or in combination. 
This means that the protection ensured by the directive becomes valid for products having a stage 
of manufacture, where they are supplied to the final user. Following this concept, raw materials, 
components  or  intermediate  products  are  as  such  normally  not  medical  devices.  Such  raw 
materials may need to present properties or characteristics which are determinant for the safety 
and quality of finished devices. It is therefore the responsibility of the manufacturer of finished 
devices to select and control by adequate means his raw materials or intermediate products”. 
The concept of "finished device" does not imply that a device when reaching the final user is 
already  in  a  state  ready  for  use.  Prior  to  use  further  preparatory  processing,  preparation, 
configuration, installation, assembling, adaptation or fitting to the needs of the user or patient 
may be required. Examples: 
- sterilisation of medical devices supplied non-sterile; 
- assembling of systems; 
- configuration of electronic equipment; 
- preparation of a dental filling; 
- fitting of contact lenses; 
- adaptation of prosthesis to the needs of the patient. 
The aforementioned activities are normally not manufacturers’ activities if they are carried out by 
the final user as part of the use or preparation for use. In this context a distinction needs to be 
made  between  a  typical  professional  activity  performed  by  a  healthcare  professional  and 
processing and assembling activities done by a specialist for such processing. 
The  definition  of  the  term  "medical  device"  together  with  the  definition  of  "accessory"  is 
determinant for the delimitation of the field of application of Directive 93/42/EEC. A slight 
difference exists between the definition in article 1(2) (a) of Directive 93/42/EEC and in article 
1(2) of Directive 90/385/EEC. 
Following the latter directive, accessories are by definition medical devices, whilst following 
Directive  93/42/EEC,  a  distinction  is  made  between  "devices"  and  "accessories".  Therefore 
within the meaning of Directive 93/42/EEC, accessories are products in their own right and, 
although being treated as devices (article 1(1)) do not follow, as a general rule, the classification 
of related devices in conjunction with which they are used. Accessories are therefore following 
Directive 93/42/EEC to be classified in their own right. 
This means that medical devices are everything from band aids to x-ray machines, contact lenses, 
hip implants, pacemakers, crutches, hospital beds and in vitro diagnostic devices. 
Medical devices are usually divided into subgroups. In Europe medical devices are divided into 
three different groups; active implantable medical devices (AIMD), general medical devices and 
in vitro diagnostic devices (IVD). These groups are recognized and used by other countries as 
well.  The  main  difference  between  countries  is  how  these  devices  are  regulated.  In  some 
countries  medical  devices  are  regulated  as  drugs  and  in  other  countries  there  are  special 
regulations for medical devices (Brolin, 2008). Medical devices can in turn be regulated as one 
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group or regulated separately, usually as one of the subgroups. In Europe general medical devices 
are divided into non invasive devices, invasive devices and active devices. An active medical 
device is a device that requires a source of energy to function. An invasive medical device is a 
product that in some way enters the human body. The device is then called invasive, surgically 
invasive or implantable depending on how the device is entering the body and the time it is 
introduced to the body. An in vitro diagnostic device is a reagent, reagent product, instrument or 
system  used  to  examine  samples  from  human  tissues  or  fluids  to  gain  information.  In  vitro 
diagnostic devices are also divided into subgroups (Landvall, 2007). 
When it comes to the classification of the medical devices, they are usually divided into different 
classes. Some countries have separate classification systems for general medical devices, active 
medical devices for implantation and in vitro diagnostic devices while other countries classify 
these products after the same system. All classification systems are risk based. Classification of 
medical devices is necessary to apply correct regulations and quality systems (Brolin, 2008). 
In the United States medical devices are classified as class I (General Controls), II (Special 
Controls) or III (Pre-market Approval) devices where class III devices represent the highest risk 
and require more control. Medical devices are classified through a classification database found 
at the FDA homepage and are given a seven digit number based on the product category (9). 
In the European Union general medical devices are classified as class I, class I sterile, class I 
measuring, class IIa, class IIb or class III where class III devices represent the highest risk. 
Active implantable medical devices are not classified and in vitro diagnostic devices have their 
own  classification  system.  Information  on  the  European  classification  system  is  found  in 
MEDDEV  2.4/1.  The  classification  rules  are  found  in  Annex  IX  of  Directive  93/42/EEG 
(Landvall, 2007). 
The  Global  Harmonization  Task  Force  (GHTF)  described  further  down  has  developed  a 
recommended classification system where medical devices are divided into class A, B, C and D 
where  class  D  represents  the  highest  risk.  This  system  is  however  a  recommendation  to 
regulatory  authorities  and  not  to  companies.  Information  on  the  GHTF  recommended 
classification  system  is  found  in  the  GHTF  document  “Principles  of  Medical  Devices 
Classification” (Brolin, 2008). 
A  nomenclature  is  usually  given  to  a  medical  device  when  it  is  classified.  There  are  two 
international nomenclatures that are very common: 
- The Emergency Care Research Institute (ECRI) nomenclature called the Universal Medical 
Device  Nomenclature  System  (UMDNS).  The  UMDNS  terms  are  harmonized  with  the 
classification system of the USA and exist in ten languages (2). 
- The Global Medical Device Nomenclature (GMDN) codes. The GMND code is built according 
to EN ISO 15225 and is collaboration between the EU, EFTA, USA and Canada (6). The GMDN 
terms only exist in English but can be translated with special software. This nomenclature system 
is required for registering a medical device within the EU (8). 
Both  systems  consist  of  defined  terms  that  describe  a  group  of  products  with  similar 
characteristics. The GMDN system is developed from 6 different nomenclature systems and the 
UMDNS system is one of them. GMDN and UMDNS harmonize with each other but GMDN has 
more terms and is therefore preferred (10). 
 
2. Quality Management Systems 
Manufacturers of medical devices need to apply suitable quality systems for their products. The 
requirements differ on the risk of the device and are usually dependent on the product class. 
Good Manufacturing Practice (GMP) is the most common requirement but there are also other 
quality  guidelines  (GXP’s).  There  is  Good  Clinical  Practice  (GCP)  describing  quality 
requirements for clinical trials, Good Laboratory Practice (GLP) describing quality requirements 
for laboratories and research organizations to ensure consistency and reliability of results, Good 488 
 
Distribution  Practice (GDP)  for  proper  distribution of  medical  products  and  Good  Vigilance 
Practice (GVP) (Brolin, 2008). 
These  guidelines  and  several  others  have  been  established  by  International  Conference  of 
Harmonization (ICH) and have been adopted by USA, EU and others. Most countries have their 
own variations of the guidelines and these are usually found at the homepage of the competent 
authority. 
The International Organization for Standardization (ISO) has developed a standard for quality 
management  system  for  medical  devices  called  ISO  13485.  This  standard  is  based  on  ISO 
9001:2000 and helps companies implement and maintain a quality management system. This 
standard is by many countries recognized as a way to reach Good Manufacturing Practice. The 
most important medical device standards concern biocompatibility ISO 10993, clinical trials ISO 
14155 and risk management ISO 14971. Active medical devices are also subject to ISO/IEC 
60601 and medical devices including software are subject to IEC 62304 (Landvall, 2007). 
 
3. Regulation of Medical Devices 
Manufacturers of medical devices need to adjust to the regulatory framework in the country 
where the product is sold. This constitutes a great problem for manufacturers, especially for 
companies  selling  their  products  in  several  countries.  Competent  authorities  worldwide  have 
begun to realize the problem and collaborate to harmonize the regulations (Brolin, 2008). 
The Global Harmonization Task Force (GHTF) is a group of representatives from regulatory 
authorities in USA, European Union, Japan, Australia and Canada that work to harmonize the 
regulations for medical devices and improve the safety, effectiveness and quality of the devices. 
The group has developed guidelines for pre-market evaluation, post-market surveillance, quality 
systems, auditing and clinical safety/performance. Many countries have begun to adopt these 
guidelines or follow the United States Food and Drug Administration (FDA) regulations or the 
European Medicines Agency (EMEA) regulations. Medical device requirements are basically the 
same in most countries but are implemented in different ways (5). 
USA 
The FDA regulates food, drugs, medical devices, biologics, cosmetics and radiation emitting 
products in the USA. FDA’s Center for Devices and Radiological Health (CDRH) is responsible 
for regulating manufacturers of medical devices. Medical devices are regulated under the Federal 
Food Drug & Cosmetic Act (FD&C Act) Part 800-1299 (Brolin, 2008). 
Manufacturers importing medical devices into the USA must designate a United States agent, 
register  the  establishment,  list  the  device,  manufacture  according  to  the  quality  system 
requirements  and  file  a  Premarket  Notification  510  (k)  or  a  Premarket  Approval.  A  post 
marketing surveillance system is required (21 CFR Part 803). Medical devices are divided into 
Class I, Class II and Class III where class I devices represent the lowest risk and class III devices 
represent the highest risk. Most Class I devices and some Class II devices are exempt from a 
Premarket  Notification  510  (k).  Class  II  devices  generally  require  a  510 (k)  while  Class  III 
devices require a Premarket Approval. Devices shall be given a device product code consisting of 
two numbers and three letters describing what type of device it is. Regulation for establishment 
registration and medical device listing is found in 21 CFR 807. The establishment registration 
shall be renewed once a year and the device listing updated once a year between October 1st and 
December 31st. Good anufacturing Practice (GMP) shall be applied according to 21 CFR Part 
820 (Brolin, 2008). 
Some devices of Class I are exempt from GMP requirements (9). The international standards for 
risk management ISO 14971 and biocompatibility ISO 10993 are accepted (10). 
European Union 
The European Medicines Agency (EMEA) is a decentralized body of the European Union (EU) 
whose  responsibility  is  to  protect  human  and  animal  health  through  the  evaluation  and 489 
 
supervision of medical products for human or animal use. This information is found at the EMEA 
homepage. Medical devices are subject to Directive 93/42/EEG and must be CE-marked before 
entering any country in the EU. Active implantable medical devices are subject to Directive 
90/385/EEG. Manufacturers of drugs and medical devices who want to sell their product to a 
country in the EU only submit one single marketing authorization application to the EMEA. The 
documentation shall be written in English, French or German. A manufacturer that does not have 
a registered place of business in the EU shall designate a single authorized representative in the 
European Union (Brolin, 2008). 
Medical devices are divided into class I, class IIa, class IIb and class III where class I also have 
the subclasses sterile and measuring. The devices shall have a GMDN code. All medical devices 
exempt class I devices require the involvement of a Notified Body. Medical devices and their 
accessories are treated as medical devices. Medical devices must meet the essential requirements 
in Annex I of Directive 93/42/EEG. Standards are used to meet and demonstrate compliance with 
the essential requirements. Manufacturers of medical devices must have a quality system (4). ISO 
13485  is  normally  used  (Landvall,  2007).  Clinical  trials  are  required  for  active  implantable 
devices, class III devices and invasive devices for long-term use of class IIa and IIb. Instructions 
for use are not necessary for class I and IIa devices if they can be used safely without them. A 
registration of a product is valid for five years (4). 
 
4. Discussion 
EU and USA have similar requirements for registration of medical devices and are striving to 
harmonize their requirements with the GHTF guidelines. A company can go far by following the 
requirements of the European Union, USA or GHTF. 
The main requirements are usually a local representative, a Certificate of Free Sale from the 
country  of  origin,  import  license  from  the  competent  authority  in  the  import  country  and 
registration of the company and the product. To accomplish this it is necessary to fulfill the 
essential  principles,  classify  the  product,  apply  Good  Manufacturing  Practice  and  risk 
management,  follow  the  labeling  requirements  and  establish  a  documented  post  market 
surveillance system (Brolin, 2008). 
Technical  documentation  is  also  necessary  and  shall  in  most  cases  be  submitted  with  the 
registration application. This is where the requirements differ. The essential principles are mainly 
the same in the countries examined but there are some differences and therefore it is necessary to 
look at these requirements country by country.  
The requirements on risk management for medical devices vary depending on the classification 
of the device. ISO 14971 is sometimes a requirement or as in most cases a recommendation. 
Clinical trials are required for more high risk devices. The devices that require clinical trials are 
about the same in all countries. Special requirements can be that the clinical trials must include 
people of the nationality of the country of interest. Labeling requirements are generally the same. 
The language shall be adjusted to the country where the product is sold. Instructions for use are 
not always necessary depending on the class of the device. Class I devices and sometimes class II 
devices (depending on the classification system) do not always require instructions for use if the 
device can be used safely without it. 
A documented post market surveillance system is necessary for all medical devices. The main 
difference  here  is  the  responsibility  of  the  sponsor  and  the  manufacturer.  The  time  for 
maintaining distribution records varies between two years and five years or the product’s life 
time. In extraordinary cases, the time is longer. A company must be aware of the timeframes of 
the registration process in different countries. This kind of thinking and strategic planning saves 
time and money (Brolin, 2008). 
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Concluding remarks 
USA and EU have similar requirements for registration of medical devices and are striving to 
harmonize  with  the  GHTF  guidelines.  Classification  of  medical  devices  is  usually  done  in 
accordance  with  the  EU  system,  FDA  system,  GHTF  guidelines  or  by  catalogue.  The 
nomenclature is UMDNS codes or GMDN where GMDN seems to be the most common variant. 
Main requirements are a local representative, a Certificate of Free Sale from the country of 
origin, import license from the competent authority in the import country and registration of the 
company and the product. 
Quality management systems and risk management systems are both in USA and EU required, 
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